More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$965345159
EPS
1.49
P/E ratio
--
Price to sales
1.91
Dividend yield
6.369%
Beta
0.426361
Previous close
$10.09
Today's open
$10.13
Day's range
$10.12 - $10.36
52 week range
$9.66 - $16.16
show more
CEO
Virgilio Deloy Capobianco Gibbon
Employees
9395
Headquarters
Belo Horizonte, Minas Gerais
Exchange
Nasdaq Global Select
Shares outstanding
93722831
Issue type
Common Stock
Consumer Staples
Education
10 Graham Value Dividend All-Stars (GVAS) Extol November
Twenty-six GVAS dividend dogs met the safer screen; ten were also ideally priced under the dividend dogcatcher rule. November's ideal buy-list includes WB, GSL, VZ, LTC, T, BZ, ZTO, CMRE, BBVA and SAN. Analyst targets and dividends imply a 42.6% average net gain across ten projected winners; ECO leads at 65.63%.
Seeking Alpha • Nov 17, 2026

Afya: 3 Key Takeaways for Long-Term Investors
Afya generated 93% of undergraduate revenue from health-related courses. Afya returned 459 million Brazilian reals to shareholders through September.
The Motley Fool • Nov 13, 2026

Afya Limited (AFYA) Q3 2026 Earnings Call Transcript
Afya Limited (AFYA) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 13, 2026

Afya: The Drop Came From Brazil, Not From The Company (Buy Rating)
Afya Limited fell about 28% in a month after Brazil's election, but Q3 2026 showed revenue up 6.1%, adjusted EBITDA up 8.7%, and EPS up 10%. Cash generation is still strong, with R$629M of FCFE in 9M26 and net debt at only 0.7x EBITDA. With the Yduqs merger, AFYA now follows YDUQ3 and the currency, and U.S. retail investors should get cash, not shares, at closing.
Seeking Alpha • Nov 13, 2026

What Afya (AFYA) Said on Its Q3 Earnings Call
Afya NASDAQ: AFYA reported third-quarter revenue growth of 6% and a higher adjusted profit margin, as gains in its undergraduate medical education business helped offset pressure in its continuing education and medical practice solutions segments.
MarketBeat • Nov 13, 2026

Afya Limited Announces Third Quarter and Nine Months 2026 Financial Results
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2026 (third quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”). These materials are n.
Business Wire • Nov 12, 2026

Afya (AFYA) Q3 Earnings Lag Estimates
Afya (AFYA) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $0.38 per share a year ago.
Zacks Investment Research • Nov 13, 2026

Afya (AFYA) Earnings Expected to Grow: Should You Buy?
Afya (AFYA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research • Nov 4, 2026

Afya Maps Yduqs Merger, BRL 2.2B Synergies and Digital Health Growth at Investor Day
Afya NASDAQ: AFYA outlined its strategy for expanding its healthcare education and digital-services ecosystem at its 2026 Afya Day, with executives emphasizing a proposed merger with Yduqs, planned synergy capture, shareholder returns and new growth avenues in medical education and physician-focused technology.
MarketBeat • Oct 23, 2026

Afya Limited (AFYA) Analyst/Investor Day Transcript
Afya Limited (AFYA) Analyst/Investor Day Transcript
Seeking Alpha • Oct 20, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Afya Limited commission-free¹. Build wealth for the long term using automated trading and transfers.